Browse the complete Report on: Market for Prescription Dermatological Drugs, 7th Edition, The


Browse All Kalorama Information Reports at  Kalorama Information

This Kalorama Information report details the various categories of prescription dermatological drugs, describes the global market and identifies major market factors that may help to shape the market for treatments in the future. The global market for prescription dermatology drugs includes products in the following categories:

• Prescription Acne and Rosacea Drugs
• Prescription Antiaging and Photodamage Drugs
• Prescription Dermatitis and Seborrhea Drugs
• Prescription Fungal Infection Drugs
• Prescription Hair Loss and Hair Removal Drugs
• Prescription Hyperpigmentation/Melasma Drugs
• Prescription Psoriasis Drugs
• Prescription Skin Cancer Drugs
• Other Prescription Skin Disorder Drugs

The pharmaceutical industry is facing a tougher environment in general, due to harder regulations for gaining approvals for mainstream products, economic issues, and a dwindling pipeline of new products. Reliance on blockbuster drugs is all but over, causing a shift of focus for many drug research and development entities. By focusing on cosmetic medications, many manufacturers are realizing less scrutiny from the FDA and a growing need in the niche markets such as dermatology. This transition will play a role in the future development of the dermatological industry over the forecast period. The global pharmaceutical sector has little choice but to continue expanding through mergers and acquisitions for some time to come. It’s a very dynamic time for the industry focusing on a worldwide market, and among the trends covered in this report are:

• Patient Compliance
• Cosmetic Dermatologists
• Melanoma Survival Rates Falter
• Phosphatidylglycerol and Psoriasis
• New Itch Gene Found
• New Filler Options
• Consumer Confusion
• Genetic Link to Psoriasis
• Biologic Dermatology
• Rx-to-OTC Switches
• Cosmeceuticals
• Antioxidants
• Polypeptides
• Teledermatology
• Reimbursement Issues
• Accutane IPledge Program
• Laser Therapy
• Narrowband Ultraviolet B
• Photodynamic Therapy
• New Oral Medications and Research for Acne
• Synthetic Lipids for Skin Healing
• Importance of Drug Delivery

The information and analysis presented in this report are based on extensive interviews with senior management of top companies in the dermatology market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with over 42 industry executives and product managers to validate and obtain expert opinion on current and future trends in the dermatological market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.

The following companies are profiled in this report:

• Allergan Inc.
• Allergan Inamed Corporation
• Barrier Therapeutics, Inc
• Bayer AG
• PharmaDerm Pharmaceuticals, Inc
• Bristol-Myers Squibb
• Collagenex (now Galderma) Pharmaceuticals
• Galderma S.A.
• Genentech, Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
• Medicis Pharmaceutical Corporation
• Merck & Company, Inc.
• Mylan Pharmaceuticals, Inc,
• Novartis Pharmaceuticals Corporation
• Nycomed Inc.
• Pfizer, Inc.
• Q-Med AB
• Roche Group (F. Hoffmann-La Roche Ltd.)
• Schering (now Merck)-Plough Corporation
• Sinclair Pharma Plc.
• SkinMedica
• Stiefel Laboratories, Inc.
• Valeant Pharmaceuticals, Inc.

All market data pertains to the global market at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year for data was 2009. Historical data are provided for each of the years 2007 to 2009, and forecast data are provided for each of the years 2009 through 2014. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2009 base year.

About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact: 

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004

http://reportsandreports.blogspot.com/ 

http://reportsandreports.proarticles.co.uk/ 

http://reportsnreports.wordpress.com/